Guy L G, Kothary R, Wall L
Institut du cancer de Montréal and the Centre de recherche du Centre hospitalier de l'Université de Montréal and Department of Medicine, Université de Montréal, Montreal, Quebec H2L 4M1, Canada.
Nucleic Acids Res. 1997 Nov 1;25(21):4400-7. doi: 10.1093/nar/25.21.4400.
We studied transgenic mice carrying the lacZ reporter gene linked to the erythroid-specific beta-globin promoter and beta-globin locus control region (LCR). Previously, we had demonstrated that the total level of expression of beta-galactosidase enzyme, which is the product of the lacZ gene, varies widely between different transgenic mice due to position effects at the sites of transgene integration. Here, using the X-gal based in situ assay for beta-galactosidase activity, we found that the percent erythroid cells that expressed the transgene also varied widely between the mice. Moreover, a kinetic analysis showed that the average beta-galactosidase content per expressing cell varied both between samples of different transgenic descent and between erythroid cells within each sample, demonstrating that the variable expression of this lacZ transgene was being controlled in a graded manner. These results suggest that the beta-globin LCR enhancers function through a graded model, which is described, rather than the binary mechanism that has been proposed previously for other enhancers.
我们研究了携带与红系特异性β-珠蛋白启动子及β-珠蛋白基因座控制区(LCR)相连的lacZ报告基因的转基因小鼠。此前我们已证明,作为lacZ基因产物的β-半乳糖苷酶的总表达水平,由于转基因整合位点的位置效应,在不同转基因小鼠之间差异很大。在此,利用基于X-gal的β-半乳糖苷酶活性原位检测法,我们发现表达转基因的红系细胞百分比在小鼠之间也有很大差异。此外,动力学分析表明,每个表达细胞的平均β-半乳糖苷酶含量在不同转基因品系的样本之间以及每个样本内的红系细胞之间均有所不同,这表明该lacZ转基因的可变表达是以分级方式受到调控的。这些结果提示,β-珠蛋白LCR增强子通过一种分级模型发挥作用,本文对此进行了描述,而非先前针对其他增强子所提出的二元机制。